We provide you with 20 years of free, institutional-grade data for RIGL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RIGL. Explore the full financial landscape of RIGL stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$338,181
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Ali-Jackson Kamil | Sale | -2,500 | $35 | $87,500 | 2026-06-24 |
| Santos David A | Sale | -874 | $29.86 | $26,098 | 2026-06-03 |
| Rojkjaer Lisa | Sale | -850 | $29.86 | $25,381 | 2026-06-03 |
| RODRIGUEZ RAUL R | Sale | -2,424 | $29.86 | $72,381 | 2026-06-03 |
| Furey Raymond J. | Sale | -877 | $29.86 | $26,187 | 2026-06-03 |
| Schorno Dean L | Sale | -928 | $29.86 | $27,710 | 2026-06-03 |
| Schorno Dean L | Derivatives Exercise | 3,381 | 2026-06-03 | ||
| Ali-Jackson Kamil | Sale | -2,500 | $29.17 | $72,925 | 2026-05-28 |
| MOOS WALTER H | Grant, award...etc | 5,750 | 2026-05-19 | ||
| MILLER MICHAEL PATRICK | Grant, award...etc | 5,750 | 2026-05-19 | ||
| LAPOINTE ANTHONY GREGG | Grant, award...etc | 5,750 | 2026-05-19 | ||
| HANNAH ALISON L. | Grant, award...etc | 5,750 | 2026-05-19 | ||
| Frohlich Mark W | Grant, award...etc | 5,750 | 2026-05-19 | ||
| Ali-Jackson Kamil | Grant, award...etc | 5,750 | 2026-05-19 | ||
| Wasman Jane | Grant, award...etc | 5,750 | 2026-05-19 | ||
| MOOS WALTER H | Sale | -4,000 | $36.36 | $145,440 | 2026-02-24 |
| MOOS WALTER H | Derivatives Exercise | 4,000 | 2026-02-24 | ||
| Furey Raymond J. | Grant, award...etc | 19,497 | 2026-02-19 | ||
| RODRIGUEZ RAUL R | Grant, award...etc | 53,915 | 2026-02-19 | ||
| Rojkjaer Lisa | Grant, award...etc | 18,894 | 2026-02-19 | ||
| Santos David A | Grant, award...etc | 19,430 | 2026-02-19 | ||
| Schorno Dean L | Grant, award...etc | 20,636 | 2026-02-19 | ||
| Schorno Dean L | Sale | -3,546 | $34.62 | $122,763 | 2026-02-12 |
| Furey Raymond J. | Sale | -3,546 | $34.62 | $122,763 | 2026-02-12 |
| Santos David A | Sale | -3,546 | $34.62 | $122,763 | 2026-02-12 |
| RODRIGUEZ RAUL R | Sale | -7,607 | $34.62 | $263,354 | 2026-02-12 |
| Rojkjaer Lisa | Sale | -3,758 | $34.62 | $130,102 | 2026-02-12 |
| Santos David A | Sale | -5,718 | $36.01 | $205,905 | 2026-02-04 |
| Schorno Dean L | Sale | -5,488 | $36.01 | $197,623 | 2026-02-04 |
| Furey Raymond J. | Sale | -3,968 | $36.01 | $142,888 | 2026-02-04 |
| RODRIGUEZ RAUL R | Sale | -84,745 | $37 | $3,135,565 | 2026-02-04 |
| RODRIGUEZ RAUL R | Derivatives Exercise | 80,000 | 2026-02-04 | ||
| MILLER MICHAEL PATRICK | Initial | 2026-02-03 | |||
| Schorno Dean L | Derivatives Exercise | 6,500 | 2025-12-29 | ||
| Frohlich Mark W | Grant, award...etc | 1,250 | 2025-05-28 | ||
| Wasman Jane | Grant, award...etc | 2,500 | 2025-05-28 | ||
| Ali-Jackson Kamil | Grant, award...etc | 2,500 | 2025-05-28 | ||
| LAPOINTE ANTHONY GREGG | Grant, award...etc | 2,500 | 2025-05-28 | ||
| MOOS WALTER H | Grant, award...etc | 2,500 | 2025-05-28 | ||
| HANNAH ALISON L. | Grant, award...etc | 2,500 | 2025-05-28 | ||
| Santos David A | Sale | -3,921 | $20.92 | $82,031 | 2025-02-06 |
| Furey Raymond J. | Sale | -2,787 | $20.92 | $58,307 | 2025-02-06 |
| RODRIGUEZ RAUL R | Sale | -9,352 | $20.92 | $195,653 | 2025-02-06 |
| Schorno Dean L | Sale | -3,770 | $20.92 | $78,872 | 2025-02-06 |
| Furey Raymond J. | Grant, award...etc | 19,717 | 2025-01-31 | ||
| Rojkjaer Lisa | Grant, award...etc | 19,717 | 2025-01-31 | ||
| RODRIGUEZ RAUL R | Grant, award...etc | 42,300 | 2025-01-31 | ||
| Schorno Dean L | Grant, award...etc | 19,717 | 2025-01-31 | ||
| Santos David A | Grant, award...etc | 19,717 | 2025-01-31 | ||
| RODRIGUEZ RAUL R | Sale | -88,156 | $22.17 | $1,954,419 | 2025-01-28 |
| RODRIGUEZ RAUL R | Derivatives Exercise | 90,000 | 2025-01-28 | ||
| Wasman Jane | Grant, award...etc | 25,000 | 2024-05-29 | ||
| MOOS WALTER H | Grant, award...etc | 25,000 | 2024-05-29 | ||
| LAPOINTE ANTHONY GREGG | Grant, award...etc | 25,000 | 2024-05-29 | ||
| Kotzin Brian L. | Grant, award...etc | 25,000 | 2024-05-29 | ||
| HANNAH ALISON L. | Grant, award...etc | 25,000 | 2024-05-29 | ||
| Ali-Jackson Kamil | Grant, award...etc | 25,000 | 2024-05-29 | ||
| Schorno Dean L | Sale | -12,628 | $1.13 | $14,265 | 2024-02-06 |
| RODRIGUEZ RAUL R | Sale | -52,894 | $1.13 | $59,786 | 2024-02-06 |
| Santos David A | Sale | -14,519 | $1.13 | $16,406 | 2024-02-06 |
| Schorno Dean L | Grant, award...etc | 209,000 | 2024-01-25 | ||
| RODRIGUEZ RAUL R | Grant, award...etc | 400,000 | 2024-01-25 | ||
| Furey Raymond J. | Grant, award...etc | 209,000 | 2024-01-25 | ||
| Santos David A | Grant, award...etc | 209,000 | 2024-01-25 | ||
| LAPOINTE ANTHONY GREGG | Grant, award...etc | 25,000 | 2023-07-12 | ||
| MOOS WALTER H | Grant, award...etc | 25,000 | 2023-07-12 | ||
| Wasman Jane | Grant, award...etc | 25,000 | 2023-07-12 | ||
| Ali-Jackson Kamil | Grant, award...etc | 25,000 | 2023-07-12 | ||
| LYONS GARY A | Grant, award...etc | 25,000 | 2023-07-12 | ||
| Kotzin Brian L. | Grant, award...etc | 25,000 | 2023-07-12 | ||
| HANNAH ALISON L. | Grant, award...etc | 25,000 | 2023-07-12 | ||
| RODRIGUEZ RAUL R | Sale | -20,340 | $1.75 | $35,595 | 2023-02-07 |
| RODRIGUEZ RAUL R | Grant, award...etc | 300,000 | 2023-02-07 | ||
| Santos David A | Sale | -5,388 | $1.66 | $8,945 | 2023-02-06 |
| Schorno Dean L | Sale | -5,389 | $1.66 | $8,946 | 2023-02-06 |
| Dummer Wolfgang | Sale | -5,389 | $1.66 | $8,946 | 2023-02-06 |
| Schorno Dean L | Grant, award...etc | 63,000 | 2023-01-30 | ||
| Santos David A | Grant, award...etc | 80,000 | 2023-01-30 |
The information provided in this report about RIGL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Rigel Pharmaceuticals, Inc(NASDAQ:RIGL) 
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocy...
Website: http://www.rigel.com
Founded: 1996
Full Time Employees: 163
Sector: Healthcare
Industry: Biotechnology